Kaleido Biosciences Financials

Kaleido Biosciences Stock Summary

Kaleido Biosciences competes with Inhibikase Therapeutics, Tempest Therapeutics, CytomX Therapeutics, Assembly Biosciences, and Instil Bio. Kaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. Kaleido Biosciences, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts. Kaleido Biosciences operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 76 people.

Kaleido Biosciences Key Financial Ratios

Kaleido Biosciences' financial ratios allow both analysts and investors to convert raw data from Kaleido Biosciences' financial statements into concise, actionable information that can be used to evaluate the performance of Kaleido Biosciences over time and compare it to other companies across industries.

Kaleido Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Kaleido Biosciences's current stock value. Our valuation model uses many indicators to compare Kaleido Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kaleido Biosciences competition to find correlations between indicators driving Kaleido Biosciences's intrinsic value. More Info.Kaleido Biosciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Kaleido Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Kaleido Biosciences' Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Kaleido Biosciences Market Pulse

Along with financial statement analysis, the daily predictive indicators of Kaleido Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Kaleido Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Kaleido Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Kaleido Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Kaleido Biosciences's daily price indicators and compare them against related drivers.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

If you are still planning to invest in Kaleido Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kaleido Biosciences' history and understand the potential risks before investing.